Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation
Enzyme and Microbial Technology · 2026-09 · 200 · 110930
DOI: 10.1016/j.enzmictec.2026.110930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2026-09. Verfasst von Chenyu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical …. Hauptthemen laut MEDLINE: Fungal Proteins. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Artemisinic alcohol dehydrogenase 1 (AaADH1) plays a pivotal role in the biosynthesis of artemisinic acid, a key precursor of the antimalarial drug artemisinin. However, its low catalytic activity and poor yield limit its industrial application. In this study, we employed a structure-guided protein engineering approach to improve the enzymatic properties of AaADH1. Substrate tunnel analysis identified key bottleneck residues that were subjected to alanine scanning mutagenesis. Among the resulting mutants, L366A displayed a 30% increase in activity and a 53% enhancement in catalytic efficiency (kcat/KM), along with a 5-fold higher expression level than the wild type (WT). Consequently, a saturation mutagenesis was performed at position 366. Compared to the WT, the kcat/KM of the L366V, L366I, and L366F mutants increased by 100%, 38%, and 16%, respectively. Molecular dynamics simulations revealed that mutations at L366 enhanced the flexibility of the catalytic pocket and stabilized the local secondary structure, thereby contributing to both improved activity and expression. These findings provide a rational framework for further optimization of AaADH1 for industrial artemisinic acid production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; School of Pharmacy, North China Univer…
- NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; NHC Key Laboratory of Systems Biology…
- School of Pharmacy, North China University of Science and Technology, Tangshan, Hebei 063210, China.
- NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Electronic address: sfan@imb.pumc.edu.…
- School of Pharmacy, Jining Medical University, Rizhao, Shandong 276800, China. Electronic address: maocaiyan@mail.jnmc.edu.cn.
- NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Electronic address: zhaoyongy@imb.pumc…
Förderung
- Beijing Natural Science Foundation
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Feng, X., Zong, L., Fan, S., Yan, M., & Yang, Z. (2026). Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation. Enzyme and Microbial Technology, 200, 110930. https://doi.org/10.1016/j.enzmictec.2026.110930
Vancouver
Wang C, Feng X, Zong L, Fan S, Yan M, Yang Z. Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation. Enzyme and Microbial Technology. 2026;200:110930. doi:10.1016/j.enzmictec.2026.110930
BibTeX
@article{Wang2026,
author = {Wang, Chenyu and Feng, Xiao and Zong, Lixia and Fan, Shuai and Yan, Maocai and Yang, Zhaoyong},
title = {Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation},
journal = {Enzyme and Microbial Technology},
year = {2026},
volume = {200},
pages = {110930},
doi = {10.1016/j.enzmictec.2026.110930}
}
EUVIMED